![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/publication/355209329/figure/fig4/AS:1079043424292875@1634275408496/Overall-survival-by-COVID-19-severity_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Adam Ondra climbs the second most difficult route of his life: Zvěřinec (9b +) - Lacrux climbing magazine Adam Ondra climbs the second most difficult route of his life: Zvěřinec (9b +) - Lacrux climbing magazine](https://b3405535.smushcdn.com/3405535/wp-content/uploads/2022/11/Will-Bosi-sichert-Adam-Ondra-beim-Projektieren-von-Zverinec-9b.jpg?lossy=2&strip=1&webp=1)
Adam Ondra climbs the second most difficult route of his life: Zvěřinec (9b +) - Lacrux climbing magazine
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/profile/Ales-Obr/publication/344130663/figure/tbl1/AS:935582410752003@1600071637611/DLTs-in-phase-1-dose-escalation_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/publication/343555075/figure/fig4/AS:11431281210480758@1702050579954/Complex-karyotype-and-total-number-of-gene-aberrations-correlates-with-shorter-survival_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/profile/Ales-Obr/publication/329187431/figure/fig1/AS:11431281173702101@1689010149546/Progression-free-survival-PFS-and-overall-survival-OS-Abbreviations-HR-hazard_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/publication/365321026/figure/fig1/AS:11431281110878472@1672800620556/Overall-survival-of-responders-vs-nonresponders-to-ibrutinib-and-of-ibrutinib-failed-vs_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/publication/343555075/figure/fig5/AS:11431281210480759@1702050580182/Patients-with-concurrent-TP53-and-CDKN2A-aberrations-have-significantly-shorter-survival_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://i1.rgstatic.net/ii/profile.image/700522176737283-1544028910414_Q512/Ales-Obr.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/profile/Ales-Obr/publication/327508766/figure/fig2/AS:1052077723766784@1627846284523/Progression-free-survival-PFS-comparison-of-observational-cohort-vs-maintenance_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/publication/343555075/figure/fig2/AS:11431281210510491@1702050579139/Survival-in-patients-with-bone-marrow-involvement-5-compared-to-patients-without_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Eliška Adamovská a Míša Smetanová míří do Asie na závody SP v boulderu - Český horolezecký svaz - ČHS Eliška Adamovská a Míša Smetanová míří do Asie na závody SP v boulderu - Český horolezecký svaz - ČHS](https://www.horosvaz.cz/res/archive/364/080757_05_759744.jpg?seek=1681393611)
Eliška Adamovská a Míša Smetanová míří do Asie na závody SP v boulderu - Český horolezecký svaz - ČHS
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/profile/Ales-Obr/publication/318130629/figure/tbl1/AS:821233704779781@1572808781864/Baseline-characteristic_Q320.jpg)
Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile
![Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile Aleš OBR | physician | MD, PhD | University Hospital Olomouc, Olomouc | Department of Hemato-Oncology | Research profile](https://www.researchgate.net/profile/Ales-Obr/publication/343983719/figure/fig1/AS:931356985016320@1599064217005/Visualisation-of-the-decision-boundary-in-the-age-TP53-mutation-burden-plane-for-three_Q320.jpg)